Skip to main content
. Author manuscript; available in PMC: 2018 Nov 1.
Published in final edited form as: Br J Haematol. 2017 Sep 7;179(4):648–656. doi: 10.1111/bjh.14918

Figure 3. Skeletal Muscle Microvascular Flow.

Figure 3

A. Resting contrast-enhanced ultrasound-derived skeletal muscle flow data is shown in controls, SCD patients not on HC and SCD patients on HC therapy. B. Skeletal muscle flow normalized to haemoglobin levels is shown in all three groups. HC: hydroxycarbamide; ns: not significant; SCD: sickle cell disease.